RED1: NICE TA359: For treating chronic lymphocytic leukaemia. (decision date - November 2015)
DO NOT PRESCRIBE (DNP)6: NICE TA328 - follicular lymphoma that is refractory to 2 prior treatments (terminated appraisal) (decision date - January 2015)
DO NOT PRESCRIBE (DNP)6 :NICE TA469 - idelalisib with ofatumumab for treating chronic lymphocytic leukaemia. (Terminated appraisal) (Decision date - September 2017)
DO NOT PRESCRIBE (DNP)6: NICE TA604 - treating refractory follicular lymphoma. (Decision date - November 2019)
NHS England drug. To be used in line with NHS England commissioning intentions